<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30380188</article-id>
<article-id pub-id-type="pmc">6214204</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.40535</article-id>
<article-id pub-id-type="manuscript">NIHMS958232</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Impact of Hypocalcemia on Full Scale IQ in Patients with 22q11.2 Deletion Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Grand</surname>
<given-names>Katheryn</given-names>
</name>
<degrees>MS, LCGC</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levitt Katz</surname>
<given-names>Lorraine E.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crowley</surname>
<given-names>T. Blaine</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moss</surname>
<given-names>Edward</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lessig</surname>
<given-names>Megan</given-names>
</name>
<degrees>CRNP</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bamba</surname>
<given-names>Vaneeta</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lord</surname>
<given-names>Katherine</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zackai</surname>
<given-names>Elaine H.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Emanuel</surname>
<given-names>Beverly S.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valverde</surname>
<given-names>Kathleen</given-names>
</name>
<degrees>MS, LCGC</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDonald-McGinn</surname>
<given-names>Donna M.</given-names>
</name>
<degrees>MS, LCGC</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Clinical Genetics Center, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA</aff>
<aff id="A2">
<label>2</label>Division of Human Genetics, 22q and You Center, The Children’s Hospital of Philadelphia, Pennsylvania, USA</aff>
<aff id="A3">
<label>3</label>Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA</aff>
<aff id="A4">
<label>4</label>Division of Endocrinology, The Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA</aff>
<aff id="A5">
<label>5</label>Genetic Counseling Program, Arcadia University, Glenside, Pennsylvania, USA</aff>
<aff id="A6">
<label>6</label>Malamut &amp; Moss, PC, Bryn Mawr, Pennsylvania, USA</aff>
<author-notes>
<corresp id="FN1"><bold>Mailing Address:</bold> Donna McDonald-McGinn, MS, LCGC, Department of Human Genetics, 34<sup>th</sup> and Civic Center Blvd, Philadelphia, PA 19104, <bold>Fax Number:</bold> (215) 590-3298, <bold>Phone Number:</bold> (215) 590-2920, <email>mcginn@email.chop.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2019</year>
</pub-date>
<volume>176</volume>
<issue>10</issue>
<fpage>2167</fpage>
<lpage>2171</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.40535-->
<abstract>
<p id="P1">Hypocalcemia has been reported in ~50% of patients 22q11.2DS and calcium regulation is known to play a role in neuronal development and synaptic plasticity. Because calcium ions play a role in neuronal function and development, we hypothesized that hypocalcemia would be associated with adverse effects on full scale IQ index (FSIQ) in patients with 22q11.2DS. A retrospective chart review cataloguing the presence or absence of hypocalcemia in 1073 subjects with a laboratory confirmed chromosome 22q11.2 deletion evaluated at the Children’s Hospital of Philadelphia was conducted. 852/1073 patients had an endocrinology evaluation with laboratory confirmed calcium levels. 466/852 (54.7%) had a diagnosis of hypocalcemia. 265/1073 subjects ranging from 0-51 years of age had both calcium levels measured and a neuropsychological evaluation yielding a FSIQ. The mean FSIQ for 146/265 patients with hypocalcemia was 77.09 (SD=13.56) and the mean FSIQ for 119/265 patients with normocalcemia was 77.27 (SD=14.25). The distribution of patients with intellectual disability (ID) (FSIQ&lt;69), borderline IQ (FSIQ 70-79), and average IQ (FSIQ&gt;80) between the hypocalcemic and normocalcemic groups was not statistically significant (χ2=0.2676, p=0.8748). Neonatal hypocalcemic seizures were not found to be associated with ID. We found no difference in FSIQ between the hypocalcemic and non-hypocalcemic patients with 22q11.2DS. As our findings differ from a previous report in adult subjects, we speculate that this may reflect a potential benefit from early treatment of hypocalcemia and may support early 22q11.2 deletion detection in order to offer prompt diagnosis and subsequent treatment of hypocalcemia.</p>
</abstract>
<kwd-group>
<kwd>22q11.2 deletion syndrome</kwd>
<kwd>hypocalcemia</kwd>
<kwd>intellectual disability</kwd>
<kwd>cognitive</kwd>
<kwd>endocrine</kwd>
<kwd>DiGeorge syndrome</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>